At this webinar, our expert panel of speakers discussed what lies ahead for the pharmaceutical industry and those it affects —from the extraordinary international collaboration in the wake of the COVID-19 pandemic to drive innovation, to tackling vaccine nationalism, data and supply chain issues, and managing surge capacity. They also considered where the next opportunities may be, and how companies can position themselves for growth and new opportunities while navigating a complex political landscape in which reputational risks are high.
Watch in full: "Global pharmaceuticals: New horizons in a post-COVID world"
See findings from the webinar presented in the graphic below.
Contacts
Partner|Boston|London
Partner|Brussels|London
Partner|London